menu
    • menu
    [{"orgOrder":0,"company":"Yaqrit","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"UNITED KINGDOM","productType":"Amino Acid","year":"2025","type":"Inapplicable","leadProduct":"Ornithine Phenylacetate","moa":"NF-?B\/NOS2","graph1":"Neurology","graph2":"Phase II","graph3":"Yaqrit","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Yaqrit \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Yaqrit \/ Undisclosed"},{"orgOrder":0,"company":"Yaqrit","sponsor":"European Foundation for Study of Chronic Liver Failure | University College, London | Hepyx Limited | CROWDHELIX LIMITED | Charite University, Berlin, Germany | University of Leipzig | Concentris Research Management Gmbh | Assistance Publique \u2013 H\u00f4pitaux d","pharmaFlowCategory":"DU","therapeuticArea":"Hepatology (Liver, Pancreatic, Gall Bladder)","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"TAK-242","moa":"Toll-like receptor 4","graph1":"Hepatology (Liver, Pancreatic, Gall Bladder)","graph2":"Phase II","graph3":"Yaqrit","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Hepatology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Yaqrit \/ European Foundation for Study of Chronic Liver Failure | University College, London | Hepyx Limited | CROWDHELIX LIMITED | Charite University, Berlin, Germany | University of Leipzig | Concentris Research Management Gmbh | Assistance Publique \u2013 H\u00f4pitaux d","highestDevelopmentStatusID":"8","companyTruncated":"Yaqrit \/ European Foundation for Study of Chronic Liver Failure | University College, London | Hepyx Limited | CROWDHELIX LIMITED | Charite University, Berlin, Germany | University of Leipzig | Concentris Research Management Gmbh | Assistance Publique \u2013 H\u00f4pitaux d"}]

    Find Clinical Drug Pipeline Developments & Deals by Yaqrit

    Menu

    Yaqrit

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Yaqrit

                            United Kingdom arrow
                            Tides Europe
                            Not Confirmed

                            Yaqrit

                            United Kingdom arrow
                            Tides Europe
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : TAK-242

                            Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)

                            Study Phase : Phase II

                            Sponsor : European Foundation for Study of Chronic Liver Failure | University College, London | Hepyx Limited | CROWDHELIX LIMITED | Charite University, Berlin, Germany | University of Leipzig | Concentris Research Management Gmbh | Assistance Publique – Hôpitaux d

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A-TANGO Phase 2 Study

                            Details : TAK-242 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Acute-On-Chronic Liver Failure.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            March 21, 2025

                            Lead Product(s) : TAK-242

                            Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)

                            Highest Development Status : Phase II

                            Sponsor : European Foundation for Study of Chronic Liver Failure | University College, London | Hepyx Limited | CROWDHELIX LIMITED | Charite University, Berlin, Germany | University of Leipzig | Concentris Research Management Gmbh | Assistance Publique – Hôpitaux d

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Yaqrit

                            United Kingdom arrow
                            Tides Europe
                            Not Confirmed

                            Yaqrit

                            United Kingdom arrow
                            Tides Europe
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ornithine Phenylacetate

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Yaqrit Prepares Phase 3 for Ammonia Scavenger in Hepatic Encephalopathy

                            Details : An ammonia scavenger, L-ornithine phenylacetate (OPA), is being evaluated for treatment of patients suffering from acute hepatic encephalopathy.

                            Product Name : Undisclosed

                            Product Type : Amino Acid

                            Upfront Cash : Inapplicable

                            February 11, 2025

                            Lead Product(s) : Ornithine Phenylacetate

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth